Oculus Innovative Sciences Announces Publication of Microcyn(R) Technology Diabetic Wound Study in Journal of College of Physicians and Surgeons Pakistan Apr 15, 2008
Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Technology Mar 27, 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers Mar 17, 2008
Oculus Innovative Sciences Announces Additional Phase II Data for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Mar 14, 2008
Oculus Innovative Sciences Announces Acceptance of Three Abstracts on the use of Microcyn(R) Technology in Diabetic Foot Ulcers by DFCon 08 Mar 12, 2008
Oculus Innovative Sciences to Announce Additional Phase II Data and Data from Two Recent International Studies at DFCon 08 Mar 11, 2008
Oculus Innovative Sciences Schedules Conference Call Today to Discuss Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference Feb 14, 2008
